Amgen
The Executive Director, Research – Technology & Innovation for Inflammation Discovery leads early discovery inflammation research at Amgen, overseeing target identification through preclinical assessment to IND and first‑in‑human studies. This senior scientific leader shapes disease‑area strategy, guides portfolio prioritization, and drives AI‑enabled discovery initiatives across immunology and inflammatory disease biology. The role also involves representing Inflammation Research in cross‑functional forums, recruiting top talent, and contributing to broader site and functional leadership initiatives.
Headquarters
Thousand Oaks, California, United States
Company Size
10001+ employees
Founded
1980
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Amgen.
53% above the average for this role
Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street's Latest Biopharma Calls Explained
1 day ago
Senior Director, Research and Development
Kiniksa Pharmaceuticals
Associate Principal Scientist, Immunology Cell Therapy Discovery
AstraZeneca
Scientist III (Immunology Discovery)
Dawar Consulting
Scientist III (Immunology Discovery)
Dawar Consulting
Associate Scientist, Immunology & Inflammation
Regeneron Pharmaceuticals
Scientist (Discovery Biology)
Cancer Research UK